Antibe Therapeutics Inc(Pre-Merger) ATBPF

ATE ( reading on ceo.ca

[Pronorvista]

Canaccord will get involved in the secondary market, it is they who hold the majority of the warrants and participated in the financing at $6.00

 Canaccord holds an important position to its advantage to move the stock

[Pronorvista]

TORONTO — (February 24, 2021) – Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX:ATE) today announced that it has closed its previously announced bought deal public offering of 6,727,500 units (the “Offered Securities”) in the capital of the Company at a price of C$6.00 per Offered Security (the “Offering Price”) for aggregate gross proceeds to the Company of C$40,365,000 (the

[Pronorvista]

Currently we have a discount of $5 per share with much more potential .

[Duster340]

that is write and as i recall they dumped within a week of the financing and ATE (sp) took a big hit.